Oncolytic herpes virus retargeted to HER-2

Cell Cycle

Volumn 8, Issue 18, 2009, Pages 2859-2860

  Lollini, Pier Luigi ^a   Menotti, Laura ^a   De Giovanni, Carla ^a   Campadelli Fiume, Gabriella ^a   Nanni, Patrizia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; HERPESVIRUS ENTRY MEDIATOR LIGAND; INTERLEUKIN 13; LAPATINIB; MONOCLONAL ANTIBODY; NECTIN 1; ONCOLYTIC HERPES VIRUS; RLM 249; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TRASTUZUMAB; UNCLASSIFIED DRUG; UROKINASE; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

BRAIN METASTASIS; BREAST CANCER; CANCER CELL; CELL DEATH; CHEMOSENSITIVITY; DRUG EFFECT; DRUG SAFETY; EDITORIAL; GLIOBLASTOMA; HUMAN; NONHUMAN; ONCOLYTIC VIROTHERAPY; OVARY CARCINOMA; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RHABDOMYOSARCOMA; VIRUS ENTRY; VIRUS REPLICATION;

HERPESVIRIDAE;

EID: 70349273743     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.18.9368     Document Type: Editorial

References (14)

1. Russell SJ, Peng KW. Trends Pharmacol Sci 2007; 28:326-333
2. Cattaneo R, et al. Nat Rev Microbiol 2008; 6:529-540
3. Guo ZS, et al. Biochim Biophys Acta 2008; 1785:217-231
4. Martuza RL, et al. Science 1991; 252:854-856
5. Markert JM, et al. Mol Ther 2009; 17:199-207.
6. Zhou G, et al. Proc Natl Acad Sci USA 2002; 99:15124-15129
7. Kamiyama H, et al. Gene Ther 2006; 13:621-629
8. Menotti L, et al. J Virol 2008; 82:10153-10161
9. Menotti L, et al. Proc Natl Acad Sci USA 2009; 106:9039-9044
10. Gonzalez-Angulo AM, et al. Oncologist 2006; 11:857-867
11. Ross JS, et al. Oncologist 2003; 8:307-325
12. Hynes NE, Lane HA. Nat Rev Cancer 2005; 5:341-354
13. Baselga J, et al. Oncologist 2006; 11 Suppl 1:4-12.
14. Zhou G, Roizman B. Proc Natl Acad Sci USA 2007; 104:4142-4146